|
HHS
MCID: HYP168
|
Hyperostosis-hyperphosphatemia Syndrome malady |
|
Sources: 22MalaCards See all sources Export this MalaCard |
MalaCards: Hyperostosis-hyperphosphatemia Syndrome, also known as cortical hyperostosis with hyperphosphatemia, is related to hyperostosis and hyperphosphatemia. An important gene associated with Hyperostosis-hyperphosphatemia Syndrome is GALNT3 (UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3)). The compound heparin have been mentioned in the context of this disorder.
|
|
Sources: 30NIH Rare Diseases, 43UMLS See all sources |
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials See all sources |
Approved drugs:Search CenterWatch for hyperostosis-hyperphosphatemia syndrome Drug clinical trials:Search ClinicalTrials for hyperostosis-hyperphosphatemia syndrome Search NIH Clinical Center for hyperostosis-hyperphosphatemia syndrome Search CenterWatch for hyperostosis-hyperphosphatemia syndrome |
|
|
|
|
|
|
|
Sources: 35PubMed See all sources |
Articles related to hyperostosis-hyperphosphatemia syndrome:
|
|
Sources: 1BioGPS See all sources |
![]() |
|
|
|
Sources: 32Novoseek , 9DrugBank, 18HMDB See all sources |
|
|
